MedPath

Effect of Zinc supplementation on symptoms of migraine

Phase 3
Conditions
migraine.
Migraine, unspecified
Registration Number
IRCT20121216011763N23
Lead Sponsor
Vice chancellor for research, University of Medical Sciences of Esfahan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

aged 20-60 years;
confirmation of migraine by neurologist;
desire to participate in present study;
do not use of oral contraceptive pill,
lack of tension headaches.

Exclusion Criteria

having chronic medical diseases;
use of supplements containing Zn, vitamin E, vitamin C,
Selenium and Beta-carotene

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Migraine symptoms ( severity, frequency and average duration of migraine attacks). Timepoint: At first and end of intervention. Method of measurement: Questionaire.;C-reactive protein (CRP). Timepoint: At first and end of intervention. Method of measurement: Laboratory analysis ( blood test).
Secondary Outcome Measures
NameTimeMethod
Migraine Disability Assessment. Timepoint: At first and end of intervention. Method of measurement: Questionaire.
© Copyright 2025. All Rights Reserved by MedPath